Material adverse change (MAC)

 

Beginning with dates of service on or after December 1, 2021, Anthem Blue Cross and Blue Shield (Anthem) will update the policy to indicate that separate reimbursement is not allowed for specimen validity testing when utilized for drug screening because it is included in the CPT and HCPCS code descriptions for presumptive and definitive drug testing. Modifiers will not override this edit; therefore, we have included this information in our Distinct Procedural Services (Modifiers 59, XE, XP, XS, XU) reimbursement policy.


For more information about this policy, visit the Reimbursement Policies page at anthem.com/provider.


1309-0921-PN-GA



Featured In:
September 2021 Anthem Provider News - Georgia